High prevalence of human T-cell lymphotropic virus type I (HTLV-I) infection and disease has been identified among Iranian-born Mashhadi Jews, an ethnically segregated, highly inbred population. To determine the origin and genetic diversity of HTLV-I in this group, 1,039 bp spanning selected regions
✦ LIBER ✦
Spastic paraparesis associated with human T-lymphotropic virus type I: A clinical, serological, and genomic study in Iranian-born Mashhadi Jews
✍ Scribed by Dr. A. Achiron; O. Pinhas-Hamiel; L. Doll; R. Djaldetti; A. Chen; I. Ziv; A. Avni; G. Frankel; E. Melamed; B. Shohat
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 560 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Human T-cell lymphotropic virus type I i
✍
V. R. Nerurkar; K. J. Song; R. R. Melland; Dr. R. Yanagihara; A. Achiron; E. Mel
📂
Article
📅
1995
🏛
John Wiley and Sons
🌐
English
⚖ 576 KB
Molecular and clinical effects of betame
✍
Carolina Alberti; Luis Cartier; María A. Valenzuela; Javier Puente; Yuetsu Tanak
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 384 KB
## Abstract There is no effective therapy for human T‐cell lymphotropic virus type I (HTLV‐I)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP). Glucocorticoids are effective to reduce the motor disability in these patients, but its role as anti‐spastic drugs is unknown. Here it is repor